We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Simulated Blood Flow Device Demonstrates How Bloodstream Infections Begin

By LabMedica International staff writers
Posted on 02 Sep 2012
A computer model of how bacteria traveling through the bloodstream clumped together may explain how bloodstream infections resist antibiotics.

A team of University of Michigan (Anne Arbor, MI, USA) scientists demonstrated that bacteria can form antibiotic-resistant clumps in a short time, even in a flowing liquid such as blood. More...
They built a device that closely simulates the turbulence and forces of blood flow, and added a strain of bacteria that is a common cause of bloodstream infections. Tiny aggregates, or clumps, of 10 to 20 bacteria formed in the flowing liquid in just two hours––about the same time, it takes human patients to develop infections.

The bioreactor used to produce the results is called a Taylor-Couette cell, and uses concentric cylinders, one of which is turned by a motor. Liquid growth medium was added to the reactor and then carefully controlled rotation produced eddies in the liquid that are similar to those of the blood. They then added Klebsiella pneumoniae bacteria, one of the most common sources of bloodstream infection. They tested two antibiotics that doctors often prescribe for sepsis: ceftriaxone and ciprofloxacin. Neither was effective at killing the clumped bacteria.

The clumps only formed when certain sticky carbohydrate molecules were present on the surface of the bacteria. The clumps persisted even when two different types of antibiotics were added suggesting that sticking together protects the floating bacteria from the drugs’ effects.
Mathematical models of the fluid dynamics of the bloodstream were created, and the conditions needed to promote bacterial growth. The models were tested using different types of containers and methods to simulate bloodstream conditions.

The clumps of bacteria were injected into mice and they stayed intact even after making many trips through the bloodstream. The clumps, about the size of a red blood cell, appeared to survive the filtering that normally takes place in the smallest blood vessels and defends the body against invaders.

The studies were described in the August 15, 2012, Journal of Infectious Diseases.

“This work demonstrates that if you let bacterial pathogens grow in fluid dynamic environments like they encounter in the bloodstream, they start to take on features that you see in patients,” said John Younger, MD, MS, professor in the department of emergency medicine at the U-M Medical School (UMMS; Anne Arbor, MI, USA) senior author of the new paper, and leader of a team of physicians, engineers, and mathematicians who have studied the origins of bloodstream infections for years. “The thing is to grow them in physical conditions that mechanically ‘feel’ like the motion of flowing blood.”

The chance of severe infection increases when someone is exposed to a source of infection, such as a central line catheter, that stays in place for days or weeks, giving tens of thousands of bacteria a chance to get into the bloodstream over time. Sepsis, which kills tens of thousands of people a year, can result when an exaggerated inflammatory response to a bloodstream infection triggers organ damage and failure.

Related Links:
University of Michigan
U-M Medical School


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Creatine Kinase-MB Assay
CK-MB Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: Schematic diagram of multimodal single-cell MSI using tapping-mode scanning probe electrospray ionization (Photo courtesy of Yoichi Otsuka)

New Technology Improves Understanding of Complex Biological Samples

Tissues are composed of a complex mixture of various cell types, which complicates our understanding of their biological roles and the study of diseases. Now, a multi-institutional team of researchers... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.